| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PTPRG PCDH18 CDH18 | 9.14e-06 | 187 | 189 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | neuron development | ROCK2 ADCY10 SETX ARHGEF28 MAP2 UBE4B CNTNAP1 PCDHAC2 TRIOBP CDH23 LAMB3 TSC2 NCK1 VPS54 ZEB2 NEDD4 CPNE6 IFRD1 SEMA6D CELSR3 PTPRG SAMD11 NFE2L2 SIPA1L1 CSPG4 CAPRIN2 KCNMA1 SECISBP2 KEL TCTN1 NIN | 1.01e-05 | 1463 | 189 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ROCK2 ADCY10 SHROOM3 ARHGEF28 MAP2 CNTNAP1 PCDHAC2 TRIOBP CDH23 LAMB3 TSC2 VPS54 ZEB2 NEDD4 CPNE6 IFRD1 HEG1 LATS1 SEMA6D CELSR3 SIPA1L1 CAPRIN2 KEL CFAP44 TCTN1 CDH18 NIN | 1.29e-05 | 1194 | 189 | 27 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection development | ROCK2 ADCY10 SETX ARHGEF28 MAP2 UBE4B CNTNAP1 PCDHAC2 TRIOBP CDH23 LAMB3 TSC2 NCK1 VPS54 ZEB2 NEDD4 CPNE6 IFRD1 SEMA6D CELSR3 PTPRG NFE2L2 SIPA1L1 CSPG4 CAPRIN2 KEL TCTN1 NIN | 1.73e-05 | 1285 | 189 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ROCK2 ADCY10 ARHGEF28 MAP2 CNTNAP1 PCDHAC2 TRIOBP CDH23 LAMB3 TSC2 ZEB2 NEDD4 IFRD1 SEMA6D CELSR3 SIPA1L1 CAPRIN2 KEL TCTN1 NIN | 1.87e-05 | 748 | 189 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | NR2C2 CENPC NCAPH2 FANCM TUBGCP5 FANCA TUBGCP3 CHFR MARF1 SHOC1 PLCB1 ZNF541 RNF212B | 2.19e-05 | 350 | 189 | 13 | GO:0051321 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ROCK2 ADCY10 ARHGEF28 MAP2 CNTNAP1 PCDHAC2 LAMB3 TSC2 VPS54 ZEB2 NEDD4 CPNE6 IFRD1 SEMA6D CELSR3 SIPA1L1 CAPRIN2 KEL TCTN1 NIN | 4.99e-05 | 802 | 189 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ROCK2 ADCY10 ARHGEF28 MAP2 CNTNAP1 PCDHAC2 LAMB3 TSC2 VPS54 ZEB2 NEDD4 CPNE6 IFRD1 SEMA6D CELSR3 SIPA1L1 CAPRIN2 KEL TCTN1 NIN | 6.66e-05 | 819 | 189 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 7.21e-05 | 192 | 189 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ROCK2 ADCY10 ARHGEF28 MAP2 CNTNAP1 PCDHAC2 LAMB3 TSC2 VPS54 ZEB2 NEDD4 CPNE6 IFRD1 SEMA6D CELSR3 SIPA1L1 CAPRIN2 KEL TCTN1 NIN | 7.48e-05 | 826 | 189 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | meiotic nuclear division | CENPC NCAPH2 FANCM FANCA CHFR MARF1 SHOC1 PLCB1 ZNF541 RNF212B | 7.71e-05 | 240 | 189 | 10 | GO:0140013 |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 1.35e-04 | 54 | 189 | 5 | GO:0006513 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ADCY10 SETX MAP2 TSC2 NCK1 ZEB2 NEDD4 IFRD1 SEMA6D PTPRG NFE2L2 SIPA1L1 CSPG4 CAPRIN2 KEL NIN | 1.71e-04 | 612 | 189 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | CENPC NCAPH2 FANCM FANCA CHFR MARF1 SHOC1 PLCB1 ZNF541 RNF212B | 1.90e-04 | 268 | 189 | 10 | GO:1903046 |
| Domain | Cadherin_CS | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 1.37e-06 | 109 | 185 | 9 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 1.86e-06 | 113 | 185 | 9 | PS00232 |
| Domain | Cadherin | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 1.86e-06 | 113 | 185 | 9 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 2.00e-06 | 114 | 185 | 9 | PS50268 |
| Domain | - | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 2.00e-06 | 114 | 185 | 9 | 2.60.40.60 |
| Domain | CA | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 2.16e-06 | 115 | 185 | 9 | SM00112 |
| Domain | Cadherin-like | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 2.32e-06 | 116 | 185 | 9 | IPR015919 |
| Domain | Cadherin | PCDHA9 PCDHAC2 CDH23 PCDHA7 PCDHA4 PCDH17 CELSR3 PCDH18 CDH18 | 2.67e-06 | 118 | 185 | 9 | IPR002126 |
| Domain | Cadherin_2 | 4.43e-05 | 65 | 185 | 6 | PF08266 | |
| Domain | Cadherin_N | 4.43e-05 | 65 | 185 | 6 | IPR013164 | |
| Domain | Actin-binding_Xin_repeat | 9.76e-05 | 2 | 185 | 2 | IPR012510 | |
| Domain | XIRP1/XIRP2 | 9.76e-05 | 2 | 185 | 2 | IPR030072 | |
| Domain | XIN | 9.76e-05 | 2 | 185 | 2 | PS51389 | |
| Domain | Xin | 9.76e-05 | 2 | 185 | 2 | PF08043 | |
| Domain | Cadherin_tail | 4.77e-04 | 37 | 185 | 4 | PF15974 | |
| Domain | Pkinase_C | 4.77e-04 | 37 | 185 | 4 | IPR017892 | |
| Domain | Cadherin_CBD | 4.77e-04 | 37 | 185 | 4 | IPR031904 | |
| Pubmed | AGAP5 SHROOM3 ABCA2 SETX CAND2 CDC42BPA CEP162 TRIOBP ADCY9 CELSR3 LMO7 SETBP1 CAPRIN2 TNRC6A EHMT1 PLCB1 ZBTB5 RPRD2 WDR90 NIN | 1.71e-11 | 529 | 191 | 20 | 14621295 | |
| Pubmed | PRUNE2 DNAJC16 TRIOBP CHD7 ADCY9 ZNRF3 LMO7 SIPA1L1 SETBP1 SEC16A EHMT1 PLCB1 RPRD2 NIN | 3.31e-11 | 225 | 191 | 14 | 12168954 | |
| Pubmed | NELFE ROCK2 TPR HAUS6 MYBBP1A SETX TRMT1 ADAR PDIA6 FASN LMO7 SEC16A NUP133 ZNF638 NHS RPRD2 PARN PKN2 LAS1L | 5.70e-11 | 503 | 191 | 19 | 16964243 | |
| Pubmed | PPP4R1 ABCA2 HIVEP2 ANK2 UBE4B ZNF584 CNTNAP1 MYRIP TRIOBP NCKAP5 TSC2 NCK1 NCAPH2 VPS54 VPS26A ZFC3H1 REV3L TUBGCP5 ZEB2 DHX30 HMG20A CELSR3 LMO7 NFE2L2 MICAL2 SIPA1L1 ZBTB5 PCMTD2 YME1L1 | 1.15e-10 | 1285 | 191 | 29 | 35914814 | |
| Pubmed | NR2C2 MYBBP1A SHROOM3 CAND2 CDC42BPA ANK2 CENPC MAP2 DNAJC16 TRIOBP PFAS FAM98A ZFC3H1 ADCY9 DMXL1 SLC4A2 DHX30 PCF11 DNAJB13 PDIA6 TUBGCP3 NUP133 EHMT1 MMGT1 PKN2 EMD LAS1L SMCR8 YME1L1 NIN | 7.58e-10 | 1487 | 191 | 30 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SHROOM3 ABCA2 HIVEP2 CDC42BPA UBE4B TRMT1 LAMB3 PFAS TSC2 MLLT10 REV3L ADCY9 DHX30 FANCA JAK3 FASN HEG1 LLGL2 CELSR3 ZNRF3 CSPG4 SEC16A EHMT1 WDR90 TJP3 | 2.37e-09 | 1105 | 191 | 25 | 35748872 |
| Pubmed | PPP4R1 MYBBP1A CDC42BPA CENPC CEP162 TRIOBP PFAS ADCY9 HNRNPL PCF11 RFTN1 PDIA6 PTPRG SEC16A TNRC6A NUP133 KCNMA1 ZNF638 NHS EMD TNS1 YME1L1 PTPN20 NIN | 4.11e-09 | 1049 | 191 | 24 | 27880917 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NELFE TPR NR2C2 MYBBP1A SETX CENPC CHD7 FAM98A FANCM ADAR HNRNPL HMG20A PCF11 BPTF IFRD1 SEC16A MARF1 ZNF638 RPRD2 PARN EMD LAS1L | 1.67e-08 | 954 | 191 | 22 | 36373674 |
| Pubmed | ROCK2 TPR CACNB1 MAP2K4 MYBBP1A SHROOM3 ANK2 CNTNAP1 ARHGEF12 TRIOBP TSC2 CHD7 ZEB2 NEDD4 SIPA1L1 SEC16A KCNMA1 EHMT1 PLCB1 PARN TNS1 SEC23A | 1.97e-08 | 963 | 191 | 22 | 28671696 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NR2C2 MYBBP1A SETX CHD7 NCAPH2 ZFC3H1 FANCM ADAR ZNF768 HNRNPL HMG20A FANCA BPTF MYPOP LIN37 LMO7 POLR1E NFE2L2 SUPT7L NUP133 EHMT1 ZNF638 RPRD2 EMD LAS1L | 5.26e-08 | 1294 | 191 | 25 | 30804502 |
| Pubmed | EEFSEC SP3 SHROOM3 SETX CDC42BPA DNAJC16 ARHGEF12 TRIOBP CHD7 FAM98A ZFC3H1 ZNF768 DHX30 HMG20A PCF11 RFTN1 PDIA6 IFRD1 POLR1E CRACDL SIPA1L1 SUPT7L TNRC6A EHMT1 PARN LAS1L YME1L1 | 5.94e-08 | 1497 | 191 | 27 | 31527615 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NELFE ROCK2 TPR MYBBP1A UBE4B CHD7 ZNF768 PCF11 BPTF PDIA6 FASN LATS1 LMO7 SIPA1L1 SEC16A ZNF638 KIAA1958 PKN2 TOPORS | 6.39e-08 | 774 | 191 | 19 | 15302935 |
| Pubmed | HAUS6 MYBBP1A SHROOM3 SETX CDC42BPA DNAJC16 CEP162 MUC16 ADCY9 DMXL1 PCF11 SEC16A TNRC6A EHMT1 ZNF638 EMD ATP1A1 SMCR8 SEC23A | 6.79e-08 | 777 | 191 | 19 | 35844135 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NELFE CRTC3 SHROOM3 SETX HIVEP2 ARHGEF28 CDC42BPA MAP2 CEP162 TSC2 FAM98A PLEKHG2 NEDD4 IFRD1 LATS1 LMO7 SAMD11 SIPA1L1 SEC16A NHS | 6.92e-08 | 861 | 191 | 20 | 36931259 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ROCK2 CDC42BPA ANK2 DNAJC16 ADCY9 SLC4A2 LLGL2 PTPRG MICAL2 CRACDL CSPG4 PLCB1 PKN2 ATP1A1 DCBLD2 PCDH18 | 1.21e-07 | 569 | 191 | 16 | 30639242 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR MYBBP1A SETX CENPC UBE4B PFAS CHD7 FAM98A VPS26A ADAR HNRNPL DHX30 PDIA6 FASN POLR1E MICAL2 TUBGCP3 SEC16A NUP133 ZNF638 PKN2 EMD LAS1L YME1L1 SEC23A | 1.23e-07 | 1353 | 191 | 25 | 29467282 |
| Pubmed | PPP4R1 SFXN4 EEFSEC SETX ARHGEF28 DNAJC16 LAMB3 PFAS RSPRY1 SLC4A2 FANCA PDIA6 LLGL2 TUBGCP3 MARF1 ZNF638 PARN | 1.34e-07 | 650 | 191 | 17 | 38777146 | |
| Pubmed | TPR NR2C2 MYBBP1A CDC42BPA RIOX1 FAM98A ZFC3H1 ADAR HNRNPL DHX30 PCF11 FASN LMO7 TUBGCP3 NUP133 EHMT1 ZNF638 EMD LAS1L | 2.55e-07 | 847 | 191 | 19 | 35850772 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.06e-07 | 80 | 191 | 7 | 10716726 | |
| Pubmed | ROCK2 TPR HAUS6 MYBBP1A CDC42BPA ANK2 ARHGEF12 NCK1 ADCY9 PDIA6 FASN LATS1 SEC16A PKN2 EMD ATP1A1 SMCR8 | 4.43e-07 | 708 | 191 | 17 | 39231216 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ROCK2 TPR MAP2K4 MYBBP1A SHROOM3 SETX CHD7 PCF11 FASN LMO7 TUBGCP3 ZNF638 PKN2 LAS1L SEC23A | 9.05e-07 | 582 | 191 | 15 | 20467437 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | FAM98A NCAPH2 MLLT10 ADAR HNRNPL DHX30 BPTF FASN SIPA1L1 TUBGCP3 ZNF638 LAS1L | 1.11e-06 | 370 | 191 | 12 | 22922362 |
| Pubmed | 1.15e-06 | 15 | 191 | 4 | 15640798 | ||
| Pubmed | NR2C2 MYBBP1A CDC42BPA CHD7 MLLT10 ZNF768 ZEB2 HNRNPL DHX30 HMG20A PCF11 BPTF LIN37 SAMD11 SUPT7L SEC16A TNRC6A MARF1 EHMT1 ZNF638 RPRD2 EMD ATP1A1 LAS1L | 1.22e-06 | 1429 | 191 | 24 | 35140242 | |
| Pubmed | NELFE PPP4R1 TPR SP3 HAUS6 ARHGEF28 CENPC UBE4B TRMT1 MARCHF7 PFAS TSC2 NCAPH2 VPS54 TUBGCP5 DHX30 FASN LLGL2 POLR1E SEC16A NHS PARN LAS1L | 1.22e-06 | 1327 | 191 | 23 | 32694731 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SFXN4 MYBBP1A CAND2 UBE4B DNAJC16 MARCHF7 TSC2 SLC4A2 FANCA ANKRD13A PDIA6 FASN IFRD1 ZNRF3 NUP133 EMD ATP1A1 YME1L1 SEC23A | 1.25e-06 | 942 | 191 | 19 | 31073040 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | PPP4R1 AGAP5 SHROOM3 CHD7 ITGB7 NEDD4 BPTF PTPRG SIPA1L1 TNRC6A MMGT1 PCMTD2 TCTN1 REV1 | 1.81e-06 | 536 | 191 | 14 | 15840001 |
| Pubmed | PPP4R1 AGAP5 SHROOM3 CHD7 ITGB7 NEDD4 BPTF PTPRG SIPA1L1 TNRC6A MMGT1 PCMTD2 TCTN1 REV1 | 1.89e-06 | 538 | 191 | 14 | 10512203 | |
| Pubmed | 1.98e-06 | 17 | 191 | 4 | 29911975 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | MYBBP1A TRMT1 MARCHF7 NCAPH2 ADAR HNRNPL DHX30 PDIA6 FASN LMO7 SAMD11 ZNF638 EMD LAS1L RPAP2 | 2.13e-06 | 624 | 191 | 15 | 33729478 |
| Pubmed | NELFE TPR HAUS6 MYBBP1A NCK1 ADAR BPTF FASN LATS1 LMO7 SEC16A RPRD2 PKN2 RPAP2 | 2.39e-06 | 549 | 191 | 14 | 38280479 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 2.54e-06 | 18 | 191 | 4 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 2.54e-06 | 18 | 191 | 4 | 10662547 | |
| Pubmed | TPR ZFC3H1 ADAR ZNF768 HNRNPL DHX30 POLR1E EMD ATP1A1 LAS1L ARHGAP45 | 2.63e-06 | 333 | 191 | 11 | 36779763 | |
| Pubmed | MYBBP1A CDC42BPA ADAR HNRNPL DHX30 FASN LMO7 SIPA1L1 SEC16A TNRC6A | 3.14e-06 | 274 | 191 | 10 | 34244482 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ROCK2 NR2C2 ABCA2 B4GALNT1 COL15A1 DNAJC16 CNTNAP1 LAMB3 TSC2 NCAPH2 DMXL1 SLC4A2 FANCA PDIA6 HEG1 CELSR3 MICAL2 CSPG4 MMGT1 ATP1A1 DCBLD2 | 3.21e-06 | 1201 | 191 | 21 | 35696571 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.44e-06 | 74 | 191 | 6 | 10817752 | |
| Pubmed | ROCK2 PRUNE2 HAUS6 ARHGEF28 PFAS ZFC3H1 FANCM TUBGCP5 RSPRY1 PCF11 RFTN1 TSC22D1 PCDH18 | 3.86e-06 | 493 | 191 | 13 | 15368895 | |
| Pubmed | REV3L TUBGCP5 ZNF768 SIRT5 ADCY9 HMG20A BPTF ZNRF3 POLR1E SIPA1L1 SUPT7L TUBGCP3 CAPRIN2 SEC16A TNRC6A EHMT1 TOPORS YME1L1 RPAP2 NIN | 3.88e-06 | 1116 | 191 | 20 | 31753913 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ROCK2 PPP4R1 MAP2K4 ARHGEF28 CEP162 TRMT1 PFAS TSC2 ADAR HNRNPL SLC4A2 NEDD4 SEMA6D CHFR ZNF638 PLCB1 WDR90 EMD | 3.96e-06 | 925 | 191 | 18 | 28986522 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ROCK2 CRTC3 HAUS6 MYBBP1A CAND2 CDH23 TSC2 NCAPH2 RSPRY1 DHX30 HMG20A ANKRD13A PTPRG LMO7 SIPA1L1 SEC16A MARF1 NUP133 ZNF638 LAS1L YME1L1 TCTN1 | 4.02e-06 | 1321 | 191 | 22 | 27173435 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.18e-06 | 283 | 191 | 10 | 30585729 | |
| Pubmed | 4.35e-06 | 77 | 191 | 6 | 10835267 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NELFE TPR HAUS6 MYBBP1A ANK2 PFAS ADAR DHX30 PDIA6 FASN SEC16A NUP133 ZNF638 RPRD2 PKN2 EMD ATP1A1 SMCR8 | 4.53e-06 | 934 | 191 | 18 | 33916271 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 SP3 CRTC3 SHROOM3 CHD7 MLLT10 NEDD4 LATS1 XIRP2 NFE2L2 SETBP1 WDR90 | 5.18e-06 | 430 | 191 | 12 | 35044719 |
| Pubmed | PRUNE2 HAUS6 SETX COL15A1 ECM2 KYAT1 POLR1E SEC16A SHOC1 KIAA1958 TOPORS | 7.14e-06 | 370 | 191 | 11 | 15164053 | |
| Pubmed | NELFE EEFSEC MYBBP1A SETX CDC42BPA ANK2 PCDHAC2 RIOX1 CHD7 FAM98A TBC1D8B PCF11 FASN LMO7 TUBGCP3 SEC16A TNRC6A MARF1 EMD ATP1A1 LAS1L SEC23A | 7.22e-06 | 1371 | 191 | 22 | 36244648 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 7.46e-06 | 180 | 191 | 8 | 35198878 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ROCK2 SFXN4 CAND2 DNAJC16 PFAS NCK1 NCAPH2 VPS26A HNRNPL ANKRD13A PDIA6 FASN SEC16A NUP133 EMD GPSM1 YME1L1 PTPN20 | 8.01e-06 | 974 | 191 | 18 | 28675297 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 CPAMD8 SHROOM3 HIVEP2 CDC42BPA MAP2 UBE4B MYRIP TRIOBP VPS54 HNRNPL BPTF ZBTB46 TSC22D1 IFRD1 PTPRG MICAL2 SETBP1 KCNMA1 EHMT1 ZNF638 RPRD2 RPAP2 | 8.18e-06 | 1489 | 191 | 23 | 28611215 |
| Pubmed | 8.59e-06 | 24 | 191 | 4 | 24698270 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NELFE MYBBP1A CENPC TRMT1 RIOX1 ADAR HNRNPL DHX30 BPTF RFTN1 PDIA6 FASN POLR1E ZNF638 PARN EMD ATP1A1 LAS1L | 9.84e-06 | 989 | 191 | 18 | 36424410 |
| Pubmed | 1.01e-05 | 313 | 191 | 10 | 20800603 | ||
| Pubmed | EEFSEC CRTC3 MAP2 SCG5 TRMT1 SIRT5 HNRNPL DHX30 LLGL2 LMO7 ATP1A1 TNS1 | 1.11e-05 | 464 | 191 | 12 | 32457219 | |
| Pubmed | CDC42BPA ARHGEF12 TRIOBP LMO7 SIPA1L1 TUBGCP3 NUP133 PKN2 NIN | 1.13e-05 | 251 | 191 | 9 | 29778605 | |
| Pubmed | MYBBP1A SETX CHD7 ZEB2 HMG20A BPTF TNRC6A NUP133 EHMT1 ZNF638 KIAA1958 PCMTD2 | 1.24e-05 | 469 | 191 | 12 | 27634302 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NELFE EEFSEC HAUS6 TRIOBP FAM98A ZFC3H1 ADAR LMO7 TNRC6A MARF1 EHMT1 SECISBP2 PKN2 ATP1A1 LAS1L | 1.26e-05 | 724 | 191 | 15 | 36232890 |
| Pubmed | MYBBP1A DNAJC16 ADAR HNRNPL DHX30 PDIA6 FASN TUBGCP3 NUP133 PKN2 EMD ATP1A1 LAS1L SEC23A | 1.31e-05 | 638 | 191 | 14 | 33239621 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MYBBP1A ARHGEF12 FAM98A TUBGCP5 HNRNPL DMXL1 DHX30 CDAN1 SIPA1L1 TUBGCP3 KCNMA1 PLCB1 | 1.40e-05 | 475 | 191 | 12 | 31040226 |
| Pubmed | 1.64e-05 | 263 | 191 | 9 | 34702444 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.68e-05 | 332 | 191 | 10 | 32786267 | |
| Pubmed | MYBBP1A FAM98A ADAR ZNF768 SLC4A2 PDIA6 FASN NUP133 EMD ATP1A1 LAS1L SEC23A | 1.69e-05 | 484 | 191 | 12 | 31995728 | |
| Pubmed | TPR MYBBP1A PFAS CHD7 DHX30 BPTF FASN SEC16A NUP133 ZNF638 PARN ATP1A1 LAS1L SEC23A | 1.70e-05 | 653 | 191 | 14 | 22586326 | |
| Pubmed | 1.72e-05 | 202 | 191 | 8 | 24639526 | ||
| Pubmed | ROCK2 TPR MYBBP1A CDC42BPA PFAS RIOX1 HNRNPL DHX30 FASN LATS1 LMO7 MICAL2 SIPA1L1 SEC16A NHS EMD ATP1A1 TOPORS TJP3 RPAP2 | 1.95e-05 | 1247 | 191 | 20 | 27684187 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.08e-05 | 271 | 191 | 9 | 32433965 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | SFXN4 MYBBP1A CAND2 TRMT1 MARCHF7 PFAS TSC2 FAM98A HNRNPL DHX30 PDIA6 FASN POLR1E SEC16A NUP133 EMD ATP1A1 LAS1L YME1L1 SEC23A | 2.18e-05 | 1257 | 191 | 20 | 37317656 |
| Pubmed | 2.46e-05 | 104 | 191 | 6 | 9205841 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.46e-05 | 104 | 191 | 6 | 31240132 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | PPP4R1 SETX PFAS CHD7 LMO7 SEC16A TNRC6A SECISBP2 ATP1A1 TOPORS CFAP44 RPAP2 NIN | 2.49e-05 | 588 | 191 | 13 | 38580884 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.60e-05 | 11 | 191 | 3 | 9655502 | |
| Pubmed | Emergence of Xin demarcates a key innovation in heart evolution. | 3.00e-05 | 2 | 191 | 2 | 18682726 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23832011 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 21875659 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 38878833 | ||
| Pubmed | [Expressions of cadherin molecules CDH18 and PCDH17 in human azoospermic testes]. | 3.00e-05 | 2 | 191 | 2 | 20180417 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 26980750 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 18948268 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 21525034 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 38145746 | ||
| Pubmed | NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation. | 3.00e-05 | 2 | 191 | 2 | 38271834 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 34508659 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 38917524 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 9743358 | ||
| Pubmed | The selenocysteine-specific elongation factor contains a novel and multi-functional domain. | 3.00e-05 | 2 | 191 | 2 | 22992746 | |
| Pubmed | Polymorphisms in translesion polymerase genes influence treatment outcome in malignant mesothelioma. | 3.00e-05 | 2 | 191 | 2 | 24956248 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 17067998 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 37740860 | ||
| Pubmed | Structure of the mammalian ribosome as it decodes the selenocysteine UGA codon. | 3.00e-05 | 2 | 191 | 2 | 35709277 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23261932 | ||
| Pubmed | Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin. | 3.00e-05 | 2 | 191 | 2 | 16708114 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYBBP1A SETX CDC42BPA MAP2 TRIOBP BTBD17 CHD7 ADAR HNRNPL DHX30 HMG20A PCF11 BPTF PDIA6 TUBGCP3 EHMT1 ZNF638 EMD | 3.23e-05 | 1082 | 191 | 18 | 38697112 |
| Pubmed | CACNB1 CPAMD8 CRTC3 PSG7 SCG5 LAMB3 NCK1 REV3L TUBGCP5 ZEB2 PCDH17 NFE2L2 CSPG4 TUBGCP3 CHFR ZNF638 SECISBP2 SMCR8 TCTN1 REV1 | 3.24e-05 | 1293 | 191 | 20 | 15342556 | |
| Pubmed | 3.38e-05 | 222 | 191 | 8 | 37071664 | ||
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 3.46e-05 | 12 | 191 | 3 | 10612399 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NELFE ROCK2 TPR MYBBP1A TRMT1 PFAS TSC2 FAM98A SIRT5 HNRNPL DHX30 PDIA6 FASN SEC16A ZNF638 MMGT1 PKN2 EMD ATP1A1 SEC23A RPAP2 | 3.72e-05 | 1415 | 191 | 21 | 28515276 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MYBBP1A CAND2 UBE4B TRMT1 PFAS ADAR HNRNPL DHX30 FASN NUP133 EHMT1 EMD ATP1A1 YME1L1 | 3.85e-05 | 704 | 191 | 14 | 29955894 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MYBBP1A CENPC UBE4B CNTNAP1 ZNF696 LAMB3 ZFC3H1 ZNF768 RSPRY1 HNRNPL TSC22D1 PDIA6 FASN MICAL2 CSPG4 EMD ATP1A1 TOPORS DCBLD2 | 3.90e-05 | 1203 | 191 | 19 | 29180619 |
| Pubmed | CRTC3 SHROOM3 LNX2 CEP162 TSC2 LATS1 LMO7 SIPA1L1 SEC16A TNRC6A NIN | 3.99e-05 | 446 | 191 | 11 | 24255178 | |
| Pubmed | ROCK2 MYBBP1A ANK2 CENPC MYRIP FAM98A ZFC3H1 ZEB2 PCF11 BPTF RFTN1 PDIA6 FASN MYPOP LATS1 LMO7 CSPG4 CAPRIN2 MARF1 ATP1A1 ZNF541 | 4.87e-05 | 1442 | 191 | 21 | 35575683 | |
| Interaction | SMG7 interactions | MLLT10 HNRNPL HMG20A PCF11 FASN LATS1 SEC16A TNRC6A ZBTB5 SECISBP2 RPRD2 PARN PRKY NIN | 1.67e-06 | 319 | 186 | 14 | int:SMG7 |
| Interaction | VASP interactions | MAP2K4 XIRP1 SHROOM3 DCAF8L2 ARHGEF12 STING1 XIRP2 LMO7 SIPA1L1 TUBGCP3 SEC16A TNRC6A NHS | 3.65e-06 | 294 | 186 | 13 | int:VASP |
| Interaction | EED interactions | TPR NR2C2 MYBBP1A SHROOM3 SETX CAND2 CENPC UBE4B RIOX1 CHD7 ADAR ITGB7 HNRNPL DMXL1 NEDD4 BPTF TSC22D1 PDIA6 CPNE6 FASN LIN37 XIRP2 SIPA1L1 TUBGCP3 NUP133 KCNMA1 EHMT1 ZNF638 ATP1A1 LAS1L SEC23A | 8.93e-06 | 1445 | 186 | 31 | int:EED |
| Interaction | MAPRE3 interactions | ROCK2 CENPC MAP2 CEP162 MARCHF7 NCKAP5 FOXD4L1 LMO7 MARF1 SECISBP2 RPAP2 | 1.00e-05 | 230 | 186 | 11 | int:MAPRE3 |
| Interaction | DOT1L interactions | TPR NR2C2 MYBBP1A CDC42BPA RIOX1 FAM98A ZFC3H1 MLLT10 ADAR HNRNPL DHX30 PCF11 FASN LMO7 POLR1E TUBGCP3 NUP133 ZNF638 EMD LAS1L NIN | 1.89e-05 | 807 | 186 | 21 | int:DOT1L |
| Interaction | PARD3 interactions | SHROOM3 TMEM17 CDC42BPA HNRNPL LATS1 PTPRG LMO7 SIPA1L1 PLCB1 MMGT1 PKN2 ATP1A1 | 2.22e-05 | 298 | 186 | 12 | int:PARD3 |
| Interaction | SUMO2 interactions | TPR SETX CENPC NCAPH2 HNRNPL NEDD4 BPTF FASN LMO7 NFE2L2 EHMT1 ZNF638 PARN PKN2 LAS1L TOPORS SEC23A | 3.59e-05 | 591 | 186 | 17 | int:SUMO2 |
| Interaction | POLR1H interactions | 4.58e-05 | 70 | 186 | 6 | int:POLR1H | |
| Interaction | CPAP interactions | 5.03e-05 | 182 | 186 | 9 | int:CPAP | |
| Interaction | SMC5 interactions | NELFE TPR NR2C2 MYBBP1A SETX CENPC CHD7 FAM98A REV3L FANCM ADAR HNRNPL HMG20A PCF11 BPTF IFRD1 SEC16A MARF1 ZNF638 RPRD2 PARN EMD LAS1L | 5.13e-05 | 1000 | 186 | 23 | int:SMC5 |
| Interaction | KCNA3 interactions | ROCK2 ADCY10 DNHD1 TPR HAUS6 MYBBP1A CDC42BPA ANK2 ARHGEF12 NCK1 ADCY9 PDIA6 FASN LATS1 SIPA1L1 CAPRIN2 SEC16A PKN2 EMD ATP1A1 SMCR8 | 5.72e-05 | 871 | 186 | 21 | int:KCNA3 |
| Interaction | KLF8 interactions | NR2C2 CHD7 ZNF768 ZEB2 HNRNPL NEDD4 BPTF SAMD11 SEC16A EHMT1 ZNF638 EMD | 5.80e-05 | 329 | 186 | 12 | int:KLF8 |
| Interaction | SYNE3 interactions | SHROOM3 DNAJC16 STING1 ADCY9 PDIA6 LATS1 LMO7 SIPA1L1 SEC16A TNRC6A NUP133 SECISBP2 EMD NIN | 6.82e-05 | 444 | 186 | 14 | int:SYNE3 |
| GeneFamily | PDZ domain containing | 7.78e-04 | 152 | 129 | 6 | 1220 | |
| GeneFamily | Ring finger proteins | 8.07e-04 | 275 | 129 | 8 | 58 | |
| GeneFamily | Clustered protocadherins | 1.13e-03 | 64 | 129 | 4 | 20 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 SP3 MAP2K4 SETX HIVEP2 CDC42BPA CENPC MARCHF7 NCK1 REV3L ZEB2 ADCY9 NEDD4 PCF11 BPTF RFTN1 IFRD1 HEG1 MICAL2 SIPA1L1 TUBGCP3 NUP133 ZNF638 PARN PKN2 | 3.14e-09 | 856 | 189 | 25 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SP3 HIVEP2 CENPC NCK1 ZFC3H1 REV3L ADCY9 PCF11 BPTF HEG1 NFE2L2 MICAL2 TUBGCP3 ZNF638 | 4.24e-08 | 300 | 189 | 14 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ROCK2 MAP2K4 HIVEP2 CDC42BPA MARCHF7 NCK1 REV3L NEDD4 BPTF RFTN1 HEG1 TUBGCP3 MARF1 ZNF638 PARN PKN2 | 3.05e-07 | 466 | 189 | 16 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | PRUNE2 ARHGEF28 ANK2 NCKAP5 PTPRG SIPA1L1 SETBP1 TNRC6A NHS TNS1 | 5.01e-06 | 221 | 189 | 10 | M39222 |
| Coexpression | GENTILE_UV_LOW_DOSE_DN | 6.88e-06 | 64 | 189 | 6 | M4594 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR SP3 HAUS6 SETX HIVEP2 CENPC LAIR1 MARCHF7 VPS26A STING1 ZFC3H1 REV3L ADAR ITGB7 ZEB2 PCF11 JAK3 BPTF RFTN1 HEG1 LATS1 ZNF638 SECISBP2 ARHGAP45 YME1L1 PRKY NIN | 9.81e-06 | 1492 | 189 | 27 | M40023 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | SP3 SETX CENPC MARCHF7 VPS26A ZFC3H1 HMG20A TUBGCP3 MARF1 NUP133 PKN2 PCMTD2 REV1 | 1.55e-05 | 429 | 189 | 13 | M29 |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP | HIVEP2 CHD7 TBC1D8B NFE2L2 TUBGCP3 SEC16A CHFR KCNMA1 SECISBP2 | 1.57e-05 | 200 | 189 | 9 | M7086 |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP | 2.18e-05 | 116 | 189 | 7 | M14146 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | HIVEP2 ARHGEF28 LAMB3 STING1 PLEKHG2 SIRT5 ADCY9 NEDD4 JAK3 ANKRD13A RFTN1 HEG1 MICAL2 SETBP1 MMGT1 PCMTD2 GPSM1 | 5.66e-05 | 783 | 189 | 17 | M2488 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 9.06e-05 | 145 | 189 | 7 | M1810 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 9.97e-05 | 198 | 189 | 8 | M5018 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 1.03e-04 | 199 | 189 | 8 | M8974 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.03e-04 | 199 | 189 | 8 | M5893 | |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN | 1.03e-04 | 199 | 189 | 8 | M4310 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 1.03e-04 | 199 | 189 | 8 | M6964 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 1.07e-04 | 200 | 189 | 8 | M387 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 1.07e-04 | 200 | 189 | 8 | M4884 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.07e-04 | 200 | 189 | 8 | M6243 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ROCK2 TPR COL15A1 ECM2 ZEB2 NEDD4 HEG1 XIRP2 ZNF638 PKN2 PCDH18 | 3.18e-10 | 176 | 192 | 11 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ROCK2 SETX ARHGEF12 NCKAP5 CHD7 PCDH17 NEDD4 BPTF HEG1 PTPRG NIN | 1.23e-09 | 200 | 192 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | ROCK2 PRUNE2 SHROOM3 ARHGEF28 MAP2 TSC22D1 MICAL2 KCNMA1 NHS | 1.40e-07 | 189 | 192 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-07 | 190 | 192 | 9 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.47e-07 | 190 | 192 | 9 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.61e-07 | 192 | 192 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | PRUNE2 SHROOM3 ARHGEF28 LLGL2 ZNRF3 LMO7 KIAA1958 NHS ATP1A1 | 1.68e-07 | 193 | 192 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.68e-07 | 193 | 192 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.75e-07 | 194 | 192 | 9 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-07 | 198 | 192 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-07 | 198 | 192 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.08e-07 | 198 | 192 | 9 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.27e-07 | 200 | 192 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-07 | 200 | 192 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.14e-06 | 179 | 192 | 8 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 183 | 192 | 8 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 183 | 192 | 8 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-06 | 184 | 192 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-06 | 184 | 192 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 185 | 192 | 8 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-06 | 186 | 192 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-06 | 187 | 192 | 8 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.64e-06 | 188 | 192 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.71e-06 | 189 | 192 | 8 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-06 | 190 | 192 | 8 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 191 | 192 | 8 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.85e-06 | 191 | 192 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-06 | 192 | 192 | 8 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-06 | 192 | 192 | 8 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 196 | 192 | 8 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 197 | 192 | 8 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-06 | 198 | 192 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.42e-06 | 198 | 192 | 8 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-06 | 199 | 192 | 8 | 456460c761e26ed4b1d88d9bee4d2a7c9bd9d416 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-06 | 199 | 192 | 8 | 5263338242f95c04690d0795749ccc20b0d19f7a | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-06 | 199 | 192 | 8 | c11365653c69a5dfb37946231f8af05149a61a71 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.51e-06 | 199 | 192 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.60e-06 | 200 | 192 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.60e-06 | 200 | 192 | 8 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.60e-06 | 200 | 192 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.60e-06 | 200 | 192 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.60e-06 | 200 | 192 | 8 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.23e-06 | 170 | 192 | 7 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.23e-06 | 170 | 192 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 173 | 192 | 7 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 177 | 192 | 7 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 177 | 192 | 7 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 177 | 192 | 7 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Neuronal-Cortical_neuron|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 34 | 192 | 4 | 6c9c477b43009cded5a2e1a1792c32c40d9309a8 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 182 | 192 | 7 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 183 | 192 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 184 | 192 | 7 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-05 | 184 | 192 | 7 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 184 | 192 | 7 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 184 | 192 | 7 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.54e-05 | 184 | 192 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 184 | 192 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.60e-05 | 185 | 192 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 186 | 192 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 187 | 192 | 7 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 187 | 192 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 187 | 192 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 188 | 192 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-05 | 188 | 192 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 190 | 192 | 7 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 191 | 192 | 7 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 191 | 192 | 7 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 191 | 192 | 7 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 192 | 192 | 7 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 192 | 192 | 7 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 192 | 192 | 7 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-05 | 192 | 192 | 7 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 192 | 192 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 193 | 192 | 7 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.10e-05 | 193 | 192 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-05 | 194 | 192 | 7 | 1b382508453c5b08fb617f626b230adf3b6cff99 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 194 | 192 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 194 | 192 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 195 | 192 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 195 | 192 | 7 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-05 | 195 | 192 | 7 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-05 | 195 | 192 | 7 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.32e-05 | 196 | 192 | 7 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 196 | 192 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 197 | 192 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 2.39e-05 | 197 | 192 | 7 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 197 | 192 | 7 | 8951787ed1f7ac1772a6ef0ba2dd44c51fd3c47b | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.47e-05 | 198 | 192 | 7 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 198 | 192 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 198 | 192 | 7 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 134 | 192 | 6 | bffd6ce8998368d4f486b64c220eab3a44ba147b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 199 | 192 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 199 | 192 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.55e-05 | 199 | 192 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 199 | 192 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-05 | 200 | 192 | 7 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-05 | 200 | 192 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-05 | 200 | 192 | 7 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-05 | 200 | 192 | 7 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.64e-05 | 200 | 192 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; HL60; HG-U133A | LAIR1 TRMT1 MARCHF7 MLLT10 ZEB2 DMXL1 SLC4A2 PDIA6 IFRD1 EHMT1 YME1L1 | 5.19e-07 | 190 | 187 | 11 | 1372_UP |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | CACNB1 CEP162 ARHGEF12 ADCY9 RFTN1 TUBGCP3 KCNMA1 PLCB1 CFAP44 DCBLD2 | 5.36e-06 | 196 | 187 | 10 | 6950_UP |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | ROCK2 ABCA2 CEP162 ARHGEF12 CHD7 MLLT10 NEDD4 LIN37 TOPORS TNS1 | 5.36e-06 | 196 | 187 | 10 | 4469_DN |
| Disease | neutrophil count | PRUNE2 CPAMD8 PCDHA9 HIVEP2 CDC42BPA ARHGEF12 CDH23 MARCHF7 PCDHA7 PCDHA4 NCK1 CHD7 PLEKHG2 VWA7 ADAR HMG20A FANCA ANKRD13A DCUN1D2 MICAL2 TNRC6A PLCB1 RPRD2 PKN2 ATP1A1 ARHGAP45 | 6.40e-07 | 1382 | 186 | 26 | EFO_0004833 |
| Disease | 1,5 anhydroglucitol measurement | 3.21e-05 | 29 | 186 | 4 | EFO_0008009 | |
| Disease | Malignant neoplasm of breast | MAP2K4 XIRP1 MAN2C1 ANK2 ADAR ZEB2 HNRNPL NEDD4 FASN LLGL2 SIPA1L1 SETBP1 NUP133 EHMT1 PLCB1 NHS TNS1 ZNF541 | 1.64e-04 | 1074 | 186 | 18 | C0006142 |
| Disease | selective IgA deficiency disease | 2.03e-04 | 46 | 186 | 4 | EFO_1001929 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.65e-04 | 57 | 186 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | brain cancer (implicated_via_orthology) | 5.76e-04 | 26 | 186 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | blood urea nitrogen measurement | SHROOM3 CDC42BPA TRMT1 NCK1 FANCA SETBP1 PLCB1 PKN2 PCMTD2 WDR90 | 6.29e-04 | 452 | 186 | 10 | EFO_0004741 |
| Disease | age of onset of anorexia nervosa | 8.13e-04 | 7 | 186 | 2 | OBA_2050099 | |
| Disease | hearing loss | 8.60e-04 | 67 | 186 | 4 | EFO_0004238 | |
| Disease | MYELODYSPLASTIC SYNDROME | 8.60e-04 | 67 | 186 | 4 | C3463824 | |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 PCDHA7 PCDHA4 THSD7B MLLT10 PCDH17 PDIA6 SEMA6D SIPA1L1 TNRC6A ZNF638 | 9.85e-04 | 566 | 186 | 11 | EFO_0007660, EFO_0008354 |
| Disease | blood pressure, chronic obstructive pulmonary disease | 1.07e-03 | 32 | 186 | 3 | EFO_0000341, EFO_0004325 | |
| Disease | gremlin-1 measurement | 1.08e-03 | 8 | 186 | 2 | EFO_0020421 | |
| Disease | intraocular pressure measurement | TTC41P ARHGEF12 TRIOBP NEDD4 FANCA ZNRF3 LMO7 CSPG4 PKN2 TNS1 | 1.54e-03 | 509 | 186 | 10 | EFO_0004695 |
| Disease | prostate carcinoma | EEFSEC SP3 HAUS6 SHROOM3 TMEM17 ANK2 PRR20G CHD7 NEDD4 ZBTB46 LMO7 SETBP1 TUBGCP3 CFAP44 | 1.63e-03 | 891 | 186 | 14 | EFO_0001663 |
| Disease | sleep measurement | 1.69e-03 | 135 | 186 | 5 | EFO_0004870 | |
| Disease | C-reactive protein measurement | SP3 ARHGEF28 UBE4B CHD7 MLLT10 ADAR ADCY9 PCDH17 FANCA BPTF ZBTB46 MYPOP LATS1 NFE2L2 SEC16A PCMTD2 ARMH4 | 1.70e-03 | 1206 | 186 | 17 | EFO_0004458 |
| Disease | information processing speed | 2.08e-03 | 85 | 186 | 4 | EFO_0004363 | |
| Disease | kidney cancer (implicated_via_orthology) | 2.09e-03 | 11 | 186 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | stroke | 2.24e-03 | 144 | 186 | 5 | EFO_0000712 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.26e-03 | 87 | 186 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | initial pursuit acceleration | 2.26e-03 | 87 | 186 | 4 | EFO_0008434 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.95e-03 | 13 | 186 | 2 | C1846647 | |
| Disease | hearing impairment | 3.48e-03 | 98 | 186 | 4 | C1384666 | |
| Disease | brain connectivity measurement | 4.02e-03 | 400 | 186 | 8 | EFO_0005210 | |
| Disease | Weight Gain | 4.02e-03 | 102 | 186 | 4 | C0043094 | |
| Disease | monocyte count | EEFSEC CDC42BPA ARHGEF12 CDH23 MARCHF7 NCK1 MLLT10 VWA7 ADCY9 FANCA IFRD1 TLR5 PLCB1 PKN2 ATP1A1 ARHGAP45 RPAP2 | 4.28e-03 | 1320 | 186 | 17 | EFO_0005091 |
| Disease | visceral:abdominal adipose tissue ratio measurement | 4.34e-03 | 52 | 186 | 3 | EFO_0803318 | |
| Disease | mean corpuscular hemoglobin concentration | SCG5 PFAS TSC2 ZEB2 ADCY9 DMXL1 SLC4A2 MYPOP ZNRF3 NFE2L2 SEC16A ZNF638 PLCB1 PKN2 ARMH4 | 4.47e-03 | 1105 | 186 | 15 | EFO_0004528 |
| Disease | age-related hearing impairment | 4.63e-03 | 324 | 186 | 7 | EFO_0005782 | |
| Disease | Leukemia, Myelocytic, Acute | 4.90e-03 | 173 | 186 | 5 | C0023467 | |
| Disease | Ciliopathies | 5.25e-03 | 110 | 186 | 4 | C4277690 | |
| Disease | mean platelet volume | HAUS6 LNX2 HIVEP2 ZNF584 TRMT1 CHD7 VWA7 FANCA SETBP1 TNRC6A PLCB1 ARHGAP45 RNF212B NIN | 5.42e-03 | 1020 | 186 | 14 | EFO_0004584 |
| Disease | urinary albumin to creatinine ratio | 5.65e-03 | 179 | 186 | 5 | EFO_0007778 | |
| Disease | Bone marrow hypocellularity | 5.66e-03 | 18 | 186 | 2 | C1855710 | |
| Disease | urate measurement, bone density | NR2C2 UBE4B MARCHF7 PCDH17 HMG20A FANCA PTPRG SEC16A KCNMA1 PLCB1 | 6.12e-03 | 619 | 186 | 10 | EFO_0003923, EFO_0004531 |
| Disease | adverse effect, response to xenobiotic stimulus | 6.18e-03 | 59 | 186 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Omenn Syndrome | 6.30e-03 | 19 | 186 | 2 | C2700553 | |
| Disease | Juvenile Myelomonocytic Leukemia | 6.30e-03 | 19 | 186 | 2 | C0349639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDDFDSFQTAISENR | 181 | P23470 | |
| FSPEDLSSIFRNNST | 6 | Q6ZRG5 | |
| VSTPSSVQFFLQEDD | 146 | P04920 | |
| DTNRSTSEAQFFLRP | 761 | P78357 | |
| IEDQATFFPSSSRNR | 201 | Q75V66 | |
| SLDPVQSFSQEAVDT | 1301 | Q6UVK1 | |
| RQDTFDADTPGSRNS | 496 | Q02641 | |
| EFQAFLSRSQSPADQ | 121 | Q00973 | |
| NERSPAFTDQSSFTP | 386 | Q86TY3 | |
| ARDDRSTSFQTQLGP | 331 | A6NE02 | |
| LENTPDTAEFSREFQ | 131 | P05408 | |
| FDVIAASSEEAQNPR | 251 | O43246 | |
| SFLNRSQVDSDDVPD | 2261 | Q96M86 | |
| NSEIPETSAFFPENR | 1011 | Q96PN6 | |
| LTRDPFSSSLQNRAE | 906 | Q7L2E3 | |
| REEDTSNTTFGPADL | 296 | Q12830 | |
| DDNDNRPTFSPATLT | 2061 | Q9H251 | |
| ASGNRTDISLDDPNF | 1516 | Q9P2D1 | |
| ESFSTLDENDLLNPS | 2006 | Q9Y485 | |
| VSFQPETDNRANFSS | 431 | Q8IWY9 | |
| ESRSPVQEDNTFLED | 31 | Q96MT7 | |
| SRFQTFVQDAESNPL | 906 | Q9NZN5 | |
| QRKEEEPSSSSVFNQ | 636 | Q16853 | |
| IDFTASNGDPRSSQS | 311 | O95741 | |
| PQLSNSEEREFSPSF | 326 | P45985 | |
| NFAQRESTTTLESLP | 256 | A8MTL3 | |
| PEDQSASEITRAFDT | 301 | P49116 | |
| TVLDNNDNAPVFDRT | 231 | Q9Y5H5 | |
| QFVQSSSTFKDPERA | 871 | O14917 | |
| APVSTANSTEDARDA | 176 | Q14699 | |
| PESLSDNIFSRQSDV | 996 | P52333 | |
| IDDTSAFVSLSQPEQ | 476 | O95453 | |
| EVLDINDNSPQFSRS | 126 | Q9HCL0 | |
| ETNTEPDFNISRAES | 521 | Q8N1W1 | |
| DSSEPAVQVQLDFST | 3246 | Q01484 | |
| PSALSETSRFDNDLQ | 541 | Q8IZ07 | |
| TVLDNNDNAPVFDRT | 231 | Q9UN72 | |
| TNRDTFNDSAAPQST | 951 | Q8WXI7 | |
| SNLTPADVFFREVSQ | 681 | Q8WUM0 | |
| KSSFNVSDVARPEAA | 576 | Q92619 | |
| DRSVDLAQFSENTPL | 101 | Q96GY3 | |
| TSFRAFEDEQPSTLS | 751 | Q12791 | |
| VRVFLTDTDPNENFS | 466 | Q6P1M3 | |
| IFSRSTSTDPFVQDD | 226 | P46934 | |
| TFQPFQRSISADDDL | 106 | P18615 | |
| LIRDSESSPNDFSVS | 306 | P16333 | |
| LPFANETNSSRSTSE | 86 | O95835 | |
| PQTEEFFDLIASSQS | 546 | Q86YR5 | |
| GATSSTNNPEFVEDL | 41 | Q9NP66 | |
| ESEPQTRSPDFTNEN | 221 | P05023 | |
| ETSNNAEPGRTSNFD | 1776 | Q2LD37 | |
| QASPSESEARFRIDS | 76 | Q6GTX8 | |
| APRNESNNLASDTFI | 796 | Q8IYD8 | |
| NRSELSSSDESENFP | 1461 | Q8IYD8 | |
| FEESAGADTTQQPLS | 211 | Q8N448 | |
| GFPNDASTENRSSDQ | 61 | P0C7V8 | |
| RLDEATDSFFQNPDS | 36 | Q6PH85 | |
| EVFASRISNPSDDNS | 296 | Q9NV79 | |
| DDNEVSSATFQSLVP | 131 | Q16236 | |
| EDSFSSILSTEDPNQ | 251 | Q16236 | |
| VQAFSDSNDERESSP | 556 | Q9Y2G8 | |
| SPQREVSRSQDQFSD | 1026 | Q8WWI1 | |
| FSTGQESPTAENARL | 611 | Q9Y4W2 | |
| LETAVRATNAQFDSP | 601 | Q96CW5 | |
| PEDSSRLSISFENVD | 771 | Q96RT8 | |
| PSSSSEFDERIAAFQ | 211 | Q9ULI3 | |
| ARISDNSLAPVADFS | 196 | Q6NV74 | |
| FSFPLENQAREAVSS | 501 | Q9BQG0 | |
| AITTTINPRFQEADS | 781 | P26010 | |
| EAEDLNFRETLPSSS | 21 | Q4JDL3 | |
| VDSPASRFAGLDTNQ | 726 | O94913 | |
| RVLDTNDNSPAFDQS | 246 | Q9Y5I4 | |
| TVLDANDNAPAFDRT | 231 | Q9UN74 | |
| LDSLQNSFDSAFRPS | 236 | Q8N414 | |
| DRKTASFSSLEPQDQ | 236 | Q96EP1 | |
| DRNSTSVSEDLLEPF | 231 | P55265 | |
| SLQFVVEPSEATNRS | 96 | Q03188 | |
| SDRSQLSFLPTEAQA | 426 | Q6UUV7 | |
| FSEARQPLSEEDVAS | 876 | O15360 | |
| NDARVALSSGPQDTA | 981 | Q8IZJ3 | |
| VSSFSLDSVARNPQE | 146 | Q9BZC7 | |
| LTSPLDAVQNFSSER | 946 | O60503 | |
| SEPTRNQNFTDLLAE | 776 | Q5TB80 | |
| QVSSPERDNETFNSG | 946 | Q6IMN6 | |
| EFSGDSSEQREPTNL | 176 | O94769 | |
| RNVQPFSDEDASIET | 36 | O00458 | |
| RASPLAFNIANSSSE | 766 | Q9Y4F3 | |
| VSSQRPFQESSDNEG | 261 | Q9H992 | |
| SSPRQLFSALESDSE | 491 | Q9NTJ4 | |
| SLSPDQTRVFSAAAD | 496 | Q86Y33 | |
| EDTEAFDITALRNPS | 666 | Q13634 | |
| SNEPSSAEIFRQIAE | 36 | P59910 | |
| DFSESRNNRFSTPEQ | 476 | P14866 | |
| QRPSSLSDNFAATAA | 356 | Q9NU39 | |
| QTTPESDFNLQALRS | 821 | Q7Z4H7 | |
| RDFLTDPDTDAATIQ | 896 | Q13751 | |
| RESNLQLTDFSPSRA | 306 | Q5BKX5 | |
| FRPSDTANSSNQDAL | 101 | Q8N4V1 | |
| AVRQSVTSFPDADAF | 116 | P50402 | |
| RSSNEFPAQTEQTTA | 496 | Q96PD2 | |
| PFTSVLQISATDRDA | 976 | Q9NYQ7 | |
| RFPQLDSTSFANSRD | 1711 | P49327 | |
| ADFSSQIRSNPELAA | 1201 | O75155 | |
| PFQRSSQALAFESSA | 186 | P39059 | |
| SDFQRGPTSTSIDNI | 706 | Q5VT52 | |
| QAAAFPTEDSRTSKE | 366 | Q9H9B1 | |
| NFPLRAQVTEASSSA | 1741 | O94851 | |
| TPSNFNREVIQSDSL | 31 | Q15084 | |
| VRDASPQETQSAFSI | 541 | Q9GZY0 | |
| FNPSVNLFSSLREEE | 421 | Q96C03 | |
| EALQSPSEAFRNVTS | 226 | Q9GZS1 | |
| EPADDSSFSLSQEVL | 316 | Q86WV6 | |
| ANFTIREDANPSSRQ | 531 | Q9NXH9 | |
| QQAENSAVPTADTRS | 61 | Q96DX4 | |
| SPRDNSERNLSLTDF | 576 | Q8WUY3 | |
| REFVPSNAELDSENA | 2151 | Q8WUY3 | |
| DLSNNSSFSPDEERR | 596 | Q8TF05 | |
| TNEDVSSPASADQRI | 71 | Q6P4A7 | |
| DNVDNVPRVSTESFS | 746 | O14513 | |
| SFTSTVADLLDDPNN | 701 | Q6T4R5 | |
| QSDSPTRATDVSNQF | 1326 | Q6T4R5 | |
| PSSAEFFLQEERLTQ | 521 | Q8N4C6 | |
| TNSPSEAEEFQLEVS | 66 | Q8NCA5 | |
| PTQSQAAVAESFERE | 281 | Q16773 | |
| QLEARQTPAFSFTEA | 116 | P0DPQ3 | |
| PAQAAAAESNSREVT | 6 | O43930 | |
| PLTRENSTFSINDAA | 1406 | O43166 | |
| AQNSDIFVPESDRSD | 1381 | Q7Z333 | |
| VPSLDLFRASDSNAN | 1361 | Q5VXU9 | |
| AETQQAPRDRSSSFA | 1161 | Q8TF72 | |
| RLQENAVSPAFTSDD | 546 | Q96T21 | |
| VSALSEASTFEDPQR | 196 | Q96NU1 | |
| GEPERSSSEETLNNF | 166 | Q15714 | |
| SNLEVEASPQASSAE | 316 | O94864 | |
| QGDSRSLPFSENVSA | 16 | Q16513 | |
| ISSSNFNPREATEAV | 151 | Q13046 | |
| SFDTVARDASQPNGV | 701 | E7EW31 | |
| FLNTPTDALDQFERS | 956 | Q5VT25 | |
| VSFSEPASDAVARSN | 476 | A0A1B0GV85 | |
| TSQASPAQRDTAQAA | 256 | Q9H2D6 | |
| TEELALTSSPNFSQD | 366 | Q9H6W3 | |
| RSSFLQVFNNSPDES | 586 | Q15436 | |
| FSTDFSNPSIAQARI | 161 | Q86WD7 | |
| FRVDFSVENANPSSR | 626 | Q8TEV9 | |
| PQDFLSFTDSDLRND | 371 | P55197 | |
| NPEASTIFQRNSQTD | 106 | A6NIR3 | |
| NEFLSLDDFPDSRTN | 116 | Q6IBW4 | |
| QEESAFISEAAAPRQ | 3336 | A4UGR9 | |
| RAVFSDSNRTGPESN | 16 | Q86X19 | |
| ASTAAFDKQPQSRER | 31 | P57772 | |
| FPEVSLSQERSDASN | 291 | Q96KV7 | |
| RATQVETSFDQEAAP | 291 | O15062 | |
| QLDNSVSDDSPIFFS | 1611 | O60673 | |
| VTDPFAFSRQALQST | 51 | O15027 | |
| VNSVASRLSPAFSQE | 246 | Q9UBZ9 | |
| PSDNFEVQSLTSQRE | 411 | Q0IIM8 | |
| SSDNEQDFVSSILPG | 216 | Q8IXW5 | |
| ESSFSQEVSREQQPS | 2046 | P12270 | |
| VSPDINETNTDTDLF | 316 | Q02447 | |
| QRNPSTVEAFDLAQS | 211 | O15067 | |
| TRDENPFASLTATSQ | 216 | O95155 | |
| SFPSTANEENFRSNL | 26 | Q9HBL0 | |
| SSFPEANSGNERTIL | 536 | Q2MV58 | |
| ESDSQSPEFESQSPR | 106 | Q9H5H4 | |
| RSAEVQAAQSTEPAA | 36 | Q9H7X3 | |
| NVAADSSLDSVPRFF | 311 | Q6P2S7 | |
| VVPELSSDIDSSNFD | 371 | O75116 | |
| SSRNDSIPQEDFTPE | 196 | Q9NQ66 | |
| QDSFPVSLEQAVTDS | 496 | P11137 | |
| TSERLAETQNIAPSF | 221 | Q96TA2 | |
| ALARSSEPVQADESQ | 841 | O95049 | |
| TNEVAQPSREFASKA | 806 | Q9NS56 | |
| QRFESPESQASAEQP | 311 | O75436 | |
| EARTVSFVDVNQSSP | 416 | C9J1S8 | |
| RANFPSALQDTQESS | 901 | Q9ULT6 | |
| LTFQALPSRDSSEEE | 581 | Q9H7P9 | |
| ENFPLTLESATRSQT | 91 | A0A0K0K1G8 | |
| PSGRTVLDFNSDSNE | 261 | Q9C0I4 | |
| SSSENSDEPLNLTFI | 851 | O60315 | |
| DPDQNTFAGLARSSV | 276 | O60602 | |
| NSLSRPNSFERSESA | 806 | P31629 | |
| SRKFVVQDDPNTSDF | 621 | Q8NFY4 | |
| VAEFNTETTPATNRF | 271 | Q9NXA8 | |
| SAQEASPARQNVSSA | 376 | Q9Y6X0 | |
| EVSRANAAQDFLPTS | 106 | Q9Y334 | |
| SRANTDDFPLTLASA | 86 | A0A1B0GX49 | |
| EEGSFANSTDQEPTR | 131 | Q702N8 | |
| SNDNPSRIVNTESFV | 1546 | O60293 | |
| SRSPVFTQLEDDEQS | 61 | Q8IVC4 | |
| KQFSNISFSRDSPEE | 1206 | Q8NDV7 | |
| ISFSRDSPEENVQSN | 1211 | Q8NDV7 | |
| PFSSELISSVSQQER | 336 | Q14966 | |
| PFSSRDSNADLSVTE | 306 | Q86UZ6 | |
| PNESQSFERSVQLLD | 1521 | P49815 | |
| AVDTTSQRNASPNSE | 531 | Q9P1Q0 | |
| ATDVFTAPNSRAAEN | 346 | Q9H0D2 | |
| QDFSSLPDTRSVASD | 41 | A6NHS1 | |
| PSRTSFNDSLTFLEN | 621 | P23276 | |
| DNRSFNSDSPSIIGV | 76 | Q8N8K9 | |
| SDPSLDFLRAQQETA | 256 | Q86VE0 | |
| VNFNPQLASRETSDS | 496 | Q8NFW9 |